Replies to post #4273 on FDA Plays

[deniseann]

I'm trying to add some this morning. bid at 3.09

[barefootrunner]

I am in SNTS because of the FDA date, but also because I think it is way oversold at these levels and is still a viable, promising company. Two drugs on the market, a candidate in phase 3 under SPA, lots of cash, etc. There are many other biotechs that are only in phase 2 clinical development that have a higher market cap.

I and cccpmd666 have posted a ton of DD on $heff's board. Go over there and search the board for SNTS. I would post the links, but am on an iPhone now.